|
|
Vaccine Detail
|
vaccinia melanoma cell lysates (VMCL) Vaccine |
| Vaccine Information |
- Vaccine Name: vaccinia melanoma cell lysates (VMCL) Vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Vaccine Ontology ID: VO_0007119
- Type: vaccinia viral lysates
- Status: Research
- Immunization Route: Intramuscular injection (i.m.)
- Description: This is for Melanoma Cancer. Immunotherapy with VMCL was not associated with a statistically significant improvement in OS or RFS, with CIs not ruling out important gains from such treatment (Hersey et al., 2002).
|
| Host Response |
|
|
| References |
Hersey et al., 2002: Hersey P, Coates AS, McCarthy WH, Thompson JF, Sillar RW, McLeod R, Gill PG, Coventry BJ, McMullen A, Dillon H, Simes RJ. Adjuvant immunotherapy of patients with high-risk melanoma using vaccinia viral lysates of melanoma: results of a randomized trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002; 20(20); 4181-4190. [PubMed: 12377961].
|
|
